Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study - Test2 - elhamkhani - TriplyDB

Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study

Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study

http://www.wikidata.org/entity/Q35695245

about

Peripheral Blood Mitochondrial DNA as a Biomarker of Cerebral Mitochondrial Dysfunction following Traumatic Brain Injury in a Porcine Model The neuropathology of chronic traumatic encephalopathy.Alterations in Daytime and Nighttime Activity in Piglets after Focal and Diffuse Brain Injury.Clinical features of repetitive traumatic brain injury and chronic traumatic encephalopathy.Large animal models of traumatic brain injury.A Porcine Model of Traumatic Brain Injury via Head Rotational Acceleration.Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms.Pre-clinical models in pediatric traumatic brain injury-challenges and lessons learned.The Study and Consequences of Repetitive Traumatic Brain Injury. Introduction.Biomechanical simulation of traumatic brain injury in the rat.

P2860

Q35670557-0248D83F-18E4-460D-85C0-1BA418AF2B67 Q35920165-35370FA1-C6DA-4F2E-BBAB-676468325DC9 Q36825885-5C6354FB-FF83-470D-9630-52D670D1F04A Q38436761-12986D00-6D10-432A-9A63-DD7AA2F51EC7 Q39303687-AF69900E-5CC8-47DE-98A2-1CB6BF4B06A5 Q41356124-52464FA0-98A0-4CF8-A585-9A890F1FC729 Q47711481-428F2794-124B-4282-8CA5-DD3FA516C609 Q47834158-18C1B18A-6DDA-48ED-85F0-5BE292A34AE6 Q48215390-CA86F32B-9B88-45C9-9811-0A438D861D8A Q49962505-392694F8-74F2-4719-A3F8-492F17E5EBCF

P2860

Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study

http://www.wikidata.org/entity/Q35695245

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Establishing a Clinically Rele ...... Cyclosporin A as a Case Study

@ast

Establishing a Clinically Rele ...... Cyclosporin A as a Case Study

@en

type

label

Establishing a Clinically Rele ...... Cyclosporin A as a Case Study

@ast

Establishing a Clinically Rele ...... Cyclosporin A as a Case Study

@en

prefLabel

Establishing a Clinically Rele ...... Cyclosporin A as a Case Study

@ast

Establishing a Clinically Rele ...... Cyclosporin A as a Case Study

@en

P1433

Q35695245-5670CCE9-2E65-4E6F-B514-56BAA566D663

P1476

Q35695245-980777AB-F385-479A-A4C0-BA406B05C83C

P2093

Q35695245-485038B8-E123-4D66-AA8E-7077BC0F0F7B

Q35695245-5C279092-B546-48E3-890C-B4DFA6045751

Q35695245-6E0C515A-91C6-4971-B797-ABE06C24D375

Q35695245-8335626A-7D58-4AEE-98B4-6B68C42EEF51

Q35695245-9A11DB1F-3A63-4199-864F-E37FEA4B65A1

Q35695245-E2D0E0BA-676D-4192-86A8-EB35FBDC1E94

P2860

Q35695245-09B86754-5B48-43CB-B022-3DBE4F2D4F75

Q35695245-0C537DEA-044C-464D-AB40-450E92515ACF

Q35695245-0F85C3E1-60E2-4A1C-9C2B-841853617D38

Q35695245-109E7E1D-E7F2-4633-837F-438D762B05D1

Q35695245-1694FB7E-B7C6-41A2-B4F1-CCB103D0D429

Q35695245-17F39760-7D92-4AF7-AB0C-5D87792AC56C

Q35695245-19141763-350E-47C0-B0D8-2F9AF5287ADD

Q35695245-191EC988-9E62-40D0-9B1E-E1B6D9FF48AC

Q35695245-1ADFD96C-E341-4639-951B-AAD94A516537

Q35695245-1BF2CA3C-9D68-40EC-92DE-1FB2EDC8956B

P304

Q35695245-346A7B65-0549-4823-8A8E-5C0C9AED34C4

P31

Q35695245-A8811AFE-51EA-4E57-901C-61E85F81F605

P356

Q35695245-096EE31A-43DC-4EA0-A975-4D2E7DD209E0

P433

Q35695245-4130CA9E-528D-4CEC-B332-FE142CE0F2F9

P478

Q35695245-5E9EE283-EE88-4EFA-AED7-9C7475480357

P50

Q35695245-2FA1169F-BDF0-4ED1-BAFC-8A78D18FCDE9

Q35695245-78551DDF-4565-43F1-915C-248E1775DE7E

Q35695245-D11CFBF2-637A-4F2B-AC49-934CAE9E1C59

P577

Q35695245-C1E62FF7-9703-4A06-B1DB-C9F910F4DE89

P698

Q35695245-9A3C0274-63E6-4C62-A675-55CF7E4472BA

P932

Q35695245-2146D000-42E9-4567-8BFE-32498E402C49

P356

P1433

Brain Pathology

P1476

Establishing a Clinically Rele ...... Cyclosporin A as a Case Study

@en

P2093

Ann-Christine Duhaime

http://www.w3.org/2001/XMLSchema#string

Kathleen Propert

http://www.w3.org/2001/XMLSchema#string

Kristen Saliga

http://www.w3.org/2001/XMLSchema#string

Melissa Byro

http://www.w3.org/2001/XMLSchema#string

Sarah Sullivan

http://www.w3.org/2001/XMLSchema#string

Susan S Margulies

http://www.w3.org/2001/XMLSchema#string

P2860

A call for transparent reporting to optimize the predictive value of preclinical research

Clinical trials in head injury

Classification of traumatic brain injury for targeted therapies

Mitochondrial structure and function are disrupted by standard isolation methods

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury

Update of the stroke therapy academic industry roundtable preclinical recommendations

Policy: NIH plans to enhance reproducibility

Dose translation from animal to human studies revisited

Dopamine agonist therapy in low-response children following traumatic brain injury.

P304

289-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPA.12247

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Beth Costine-Bartell

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25904045

http://www.w3.org/2001/XMLSchema#string

P932

4459790

http://www.w3.org/2001/XMLSchema#string